Medtronic, Inc. (MDT)
-NYSE 52.49 
2.61(5.22%) 02:19 SGT - Nasdaq Real Time Price
| Prev Close: | 49.89 |
|---|
| Open: | 51.99 |
|---|
| Bid: | 52.30 x 700 |
|---|
| Ask: | 52.31 x 1100 |
|---|
| 1y Target Est: | 50.29 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | 21-May-13 |
|---|
| Day's Range: | 51.82 - 53.83 |
|---|
| 52wk Range: | 35.67 - 53.83 |
|---|
| Volume: | 11,225,348 |
|---|
| Avg Vol (3m): | 4,080,800 |
|---|
| Market Cap: | 53.22B |
|---|
| P/E (ttm): | 15.47 |
|---|
| EPS (ttm): | 3.38 |
|---|
| Div & Yield: | 1.04 (2.10%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- S&P Hits All-Time High on Dovish Fed Commentsat CNBC(Wed, 01:33 SGT)
- Midday Glance: Medical Devices companiesAP(Wed, 01:16 SGT)
- Midday Glance: Medical Devices companiesAP(Wed, 01:16 SGT)
- Stocks Gain As Bullard Signals More Fed Stimulusat TheStreet(Wed, 01:13 SGT)
- Medtronic rises on better-than-expected 4Q resultsAP(Wed, 01:07 SGT)
- Medtronic rises on better-than-expected 4Q resultsAP(Wed, 01:07 SGT)
- Early Glance: Medical Devices companiesAP(Tue, 21 May)
- Final Glance: Medical Devices companiesAP(Tue, 21 May)
- Medtronic launches 2 new implanted heart devicesAP(Mon, 6 May)
- Edwards Lifesciences cuts heart valve sales viewAP(Wed, 24 Apr)
Key Statistics
| Forward P/E (1 yr): | 13.62 |
|---|
| P/S (ttm): | 3.08 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-13)
: | 3.69 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 1.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.08 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More